Loading clinical trials...
Loading clinical trials...
The aim of this observational study is to identify the social and demographic determinants of fatigue in patients with inflammatory bowel disease in remission. Secondly, the objectives of the study are to: * Assess the impact of fatigue on the quality of life of patients with inflammatory bowel disease in remission. * To determine the profile of patients with inflammatory bowel disease in remission who are fatigued. To this end, during a consultation or hospitalization, participants will be asked to respond independently to various questionnaires (FACIT-F, DIPCare, SSQ6, questionnaire on socio-demographic determinants and IBD disk). Characteristics of the type of chronic inflammatory bowel disease will be collected from medical records. There will be no patient follow-up as part of the study. Participants may be contacted by telephone by the center's investigator within 2 weeks of the interview in the event of a partial or imprecise response.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU Bordeaux Hôpital Haut Lévêque
Bordeaux, France
CHUGA
Grenoble, France
Chu Lyon Sud _ Hcl
Lyon, France
Chu Montpellier
Montpellier, France
Start Date
January 17, 2024
Primary Completion Date
June 24, 2024
Completion Date
June 24, 2024
Last Updated
April 18, 2025
208
ACTUAL participants
Lead Sponsor
University Hospital, Grenoble
NCT06226883
NCT06082518
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions